TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis

Objective(s): Acute kidney injury (AKI) is a major component of isoproterenol (ISO) induced cardiorenal syndrome. In this study, we investigated the effect of TLR4‐IN‐C34 as a toll-like receptor (TLR)-4 inhibitor on ameliorating ISO-induced AKI and the possible molecular underlying pathways. Materia...

Full description

Bibliographic Details
Main Authors: Hadeer Abdelsalam, Manar Helal, Nashwa Abu-Elsaad
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2022-11-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:https://ijbms.mums.ac.ir/article_21157_ce4a41b7831aa4ec8af6e22372edf164.pdf
_version_ 1811335807166840832
author Hadeer Abdelsalam
Manar Helal
Nashwa Abu-Elsaad
author_facet Hadeer Abdelsalam
Manar Helal
Nashwa Abu-Elsaad
author_sort Hadeer Abdelsalam
collection DOAJ
description Objective(s): Acute kidney injury (AKI) is a major component of isoproterenol (ISO) induced cardiorenal syndrome. In this study, we investigated the effect of TLR4‐IN‐C34 as a toll-like receptor (TLR)-4 inhibitor on ameliorating ISO-induced AKI and the possible molecular underlying pathways. Materials and Methods: The study included 4 groups: control group, ISO group (rats received 100 mg/kg ISO in 2 doses 24 hr apart, SC), ISO+C341 and ISO+C343 groups (rats received 1 or 3 mg/kg TLR4‐IN‐C34 respectively twice one hour before each ISO injection, IP). Results: Obtained results showed that TLR4‐IN‐C34 injection prior to ISO decreased serum creatinine level (P<0.05). Renal tissue histopathologic changes were markedly decreased by TLR4‐IN‐C34. Renal relative expression of MAPK and MyD88 mRNA decreased significantly in both ISO+C341 and ISO+C343 groups compared with the ISO group (P<0.05). Furthermore, TLR-IN-C34 lowered the inflammatory cytokines IL-8, IL-1β, and IL-12 renal levels (P<0.05). Immunostained kidney sections showed a marked decrease in NF-κb positive cells in addition to the apoptotic marker Bax (P<0.05) by the two tested doses of TLR4‐IN‐C34. On the other hand, the expression of the antiapoptotic marker Bcl-2 by renal cells was markedly increased. Conclusion: It can be concluded that TLR4-IN-C34 ameliorates ISO-induced AKI through anti-inflammatory anti-apoptotic effects and modulation of TLR4 signaling pathways.
first_indexed 2024-04-13T17:29:23Z
format Article
id doaj.art-37c932b0b1ff456ab8e9d869717acb36
institution Directory Open Access Journal
issn 2008-3866
2008-3874
language English
last_indexed 2024-04-13T17:29:23Z
publishDate 2022-11-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj.art-37c932b0b1ff456ab8e9d869717acb362022-12-22T02:37:37ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742022-11-0125111334134010.22038/ijbms.2022.67168.1472721157TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosisHadeer Abdelsalam0Manar Helal1Nashwa Abu-Elsaad2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, EgyptObjective(s): Acute kidney injury (AKI) is a major component of isoproterenol (ISO) induced cardiorenal syndrome. In this study, we investigated the effect of TLR4‐IN‐C34 as a toll-like receptor (TLR)-4 inhibitor on ameliorating ISO-induced AKI and the possible molecular underlying pathways. Materials and Methods: The study included 4 groups: control group, ISO group (rats received 100 mg/kg ISO in 2 doses 24 hr apart, SC), ISO+C341 and ISO+C343 groups (rats received 1 or 3 mg/kg TLR4‐IN‐C34 respectively twice one hour before each ISO injection, IP). Results: Obtained results showed that TLR4‐IN‐C34 injection prior to ISO decreased serum creatinine level (P<0.05). Renal tissue histopathologic changes were markedly decreased by TLR4‐IN‐C34. Renal relative expression of MAPK and MyD88 mRNA decreased significantly in both ISO+C341 and ISO+C343 groups compared with the ISO group (P<0.05). Furthermore, TLR-IN-C34 lowered the inflammatory cytokines IL-8, IL-1β, and IL-12 renal levels (P<0.05). Immunostained kidney sections showed a marked decrease in NF-κb positive cells in addition to the apoptotic marker Bax (P<0.05) by the two tested doses of TLR4‐IN‐C34. On the other hand, the expression of the antiapoptotic marker Bcl-2 by renal cells was markedly increased. Conclusion: It can be concluded that TLR4-IN-C34 ameliorates ISO-induced AKI through anti-inflammatory anti-apoptotic effects and modulation of TLR4 signaling pathways.https://ijbms.mums.ac.ir/article_21157_ce4a41b7831aa4ec8af6e22372edf164.pdfapoptosisisoproterenolmapkmyd88nf-kappa btoll-like receptor
spellingShingle Hadeer Abdelsalam
Manar Helal
Nashwa Abu-Elsaad
TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
Iranian Journal of Basic Medical Sciences
apoptosis
isoproterenol
mapk
myd88
nf-kappa b
toll-like receptor
title TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
title_full TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
title_fullStr TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
title_full_unstemmed TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
title_short TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
title_sort tlr4 in c34 protects against acute kidney injury via modulating tlr4 myd88 nf κb axis mapk and apoptosis
topic apoptosis
isoproterenol
mapk
myd88
nf-kappa b
toll-like receptor
url https://ijbms.mums.ac.ir/article_21157_ce4a41b7831aa4ec8af6e22372edf164.pdf
work_keys_str_mv AT hadeerabdelsalam tlr4inc34protectsagainstacutekidneyinjuryviamodulatingtlr4myd88nfkbaxismapkandapoptosis
AT manarhelal tlr4inc34protectsagainstacutekidneyinjuryviamodulatingtlr4myd88nfkbaxismapkandapoptosis
AT nashwaabuelsaad tlr4inc34protectsagainstacutekidneyinjuryviamodulatingtlr4myd88nfkbaxismapkandapoptosis